Insufficient scRNA-seq data for expression of EPX at single-cell level.
Insufficient scRNA-seq data for expression of EPX at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 56.85 | 2555 / 2642 | 59% | 1.00 | 413 / 705 |
spleen | 100% | 176.57 | 241 / 241 | 0% | 0 | 0 / 0 |
ovary | 93% | 21.19 | 168 / 180 | 6% | 0.09 | 24 / 430 |
lung | 94% | 56.58 | 542 / 578 | 4% | 0.07 | 47 / 1155 |
uterus | 94% | 18.90 | 159 / 170 | 3% | 0.05 | 16 / 459 |
intestine | 90% | 14.28 | 865 / 966 | 1% | 0.02 | 4 / 527 |
bladder | 86% | 11.71 | 18 / 21 | 3% | 0.04 | 15 / 504 |
prostate | 85% | 13.17 | 209 / 245 | 1% | 0.01 | 5 / 502 |
peripheral blood | 85% | 1269.40 | 793 / 929 | 0% | 0 | 0 / 0 |
kidney | 79% | 12.24 | 70 / 89 | 6% | 0.09 | 56 / 901 |
skin | 80% | 19.24 | 1455 / 1809 | 2% | 0.03 | 9 / 472 |
thymus | 78% | 10.35 | 511 / 653 | 3% | 0.05 | 20 / 605 |
breast | 73% | 13.20 | 334 / 459 | 8% | 0.14 | 93 / 1118 |
adrenal gland | 72% | 9.22 | 187 / 258 | 7% | 0.09 | 17 / 230 |
esophagus | 78% | 10.26 | 1122 / 1445 | 0% | 0 | 0 / 183 |
stomach | 70% | 8.11 | 250 / 359 | 1% | 0.02 | 4 / 286 |
adipose | 58% | 8.22 | 703 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 57% | 6.90 | 762 / 1335 | 0% | 0 | 0 / 0 |
liver | 56% | 7.52 | 126 / 226 | 0% | 0.01 | 2 / 406 |
pancreas | 50% | 4.81 | 165 / 328 | 3% | 0.04 | 5 / 178 |
muscle | 35% | 4.47 | 281 / 803 | 0% | 0 | 0 / 0 |
heart | 34% | 4.13 | 292 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.09 | 3 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010936 | Biological process | negative regulation of macrophage cytokine production |
GO_0032714 | Biological process | negative regulation of interleukin-5 production |
GO_0042744 | Biological process | hydrogen peroxide catabolic process |
GO_0072677 | Biological process | eosinophil migration |
GO_0002215 | Biological process | defense response to nematode |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0006979 | Biological process | response to oxidative stress |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0042742 | Biological process | defense response to bacterium |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0004601 | Molecular function | peroxidase activity |
GO_0020037 | Molecular function | heme binding |
GO_0140825 | Molecular function | lactoperoxidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | EPX |
Protein name | Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] |
Synonyms | EPP EPO EPER |
Description | FUNCTION: Mediates tyrosine nitration of secondary granule proteins in mature resting eosinophils. Shows significant inhibitory activity towards Mycobacterium tuberculosis H37Rv by inducing bacterial fragmentation and lysis. . |
Accessions | ENST00000225371.6 P11678 |